ScanBalt Business Club Partner Search: A preclinical efficacy service provide with proven track record of intranasal delivery needed
An Estonian pharmaceutical company is looking to utilize nose to brain pathway for delivery of one of their drugs. A preclinical efficacy service provide with proven track record of intranasal delivery is needed to support the program. Validated intranasal administration method in rats should be in place. They can consider other species if reliable procedure is established.
Maarika Merirand Biotechnology Manager of the Connected Health Cluster Tallinn Science Park Tehnopol E: Maarika.Merirand@tehnopol.ee +372 51 781 87 +971 50 206 42 40
20 September 2018
Bioagora 2018 (Copenhagen)
19 September 2018
STZ OcuTox: Drug development know-how